Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Very High Risk Acute Lymphoblastic Leukemia in Children and Adolescents
NCT00022737Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2002
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by National Cancer Institute. Started Oct 2002; status: completed.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00022737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022737.